Roselabs Bioscience Profile
Key Indicators
- Authorised Capital ₹ 29.00 Cr
- Paid Up Capital ₹ 28.90 Cr
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 462.38 Cr
- Satisfied Charges ₹ 14.62 Cr
- Revenue Growth -55.92%
- Profit Growth 33.78%
- Ebitda 324.38%
- Net Worth -122.27%
- Total Assets -7.27%
About Roselabs Bioscience
Roselabs Bioscience Limited (RBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 06 January 2010 and has a history of 15 years and one month. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Roselabs Bioscience Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 29.00 Cr and a paid-up capital of Rs 28.90 Cr.
The company currently has active open charges totaling ₹462.38 Cr. The company has closed loans amounting to ₹14.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pawankumar Agrawal, Zameer Agrawal, and Rahul Agrawal serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290GJ2010PLC059109
- Company No.
059109
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2010
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Roselabs Bioscience Limited offer?
Roselabs Bioscience Limited offers a wide range of products and services, including Mobile Phone & Accessories, Mobile Tablet.
Who are the key members and board of directors at Roselabs Bioscience?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawankumar Agrawal  | Director | 06-Jan-2010 | Current |
| Zameer Agrawal | Director | 06-Jan-2010 | Current |
| Rahul Agrawal | Director | 21-May-2016 | Current |
Financial Performance of Roselabs Bioscience.
Roselabs Bioscience Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 55.92% decrease. The company also saw a substantial improvement in profitability, with a 33.78% increase in profit. The company's net worth observed a substantial decline by a decrease of 122.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Roselabs Bioscience?
In 2020, Roselabs Bioscience had a promoter holding of 27.40% and a public holding of 72.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Roselabs LimitedPawankumar Agrawal, Zameer Agrawal and 1 more are mutual person
- Roselabs Polymers Limited
Pawankumar Agrawal, Zameer Agrawal and 1 more are mutual person
Rlhc Private LimitedPawankumar Agrawal is a mutual person
- Pushpdant Commotrade Private Limited
Pawankumar Agrawal and Zameer Agrawal are mutual person
- Gopalka Motor Investo Pvt. Ltd.
Pawankumar Agrawal and Zameer Agrawal are mutual person
- Garison Formulation Private Limited
Rahul Agrawal is a mutual person
Charges (Loans)
₹462.38 Cr
₹14.62 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 462.20 Cr
- Axis Bank Limited : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2013 | State Bank Of India | ₹71.38 Cr | Open |
| 01 Sep 2012 | Axis Bank Limited | ₹1.76 M | Open |
| 11 Jun 2012 | State Bank Of India | ₹29.74 Cr | Open |
| 26 Oct 2010 | State Bank Of India | ₹165.67 Cr | Open |
| 26 Oct 2010 | State Bank Of India | ₹195.41 Cr | Open |
How Many Employees Work at Roselabs Bioscience?
Roselabs Bioscience has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Roselabs Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Roselabs Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
